Citations

Showing 10 of 108094 citations.

Axis II Personality Disorders Are Linked to an Adverse Course of Bipolar Disorder
Post, Robert M. , Kupka, Ralph , Suppes, Trisha, Hellemann, Gerhard , Nolen, Willem A. , Frye, Mark A. , Keck, Paul E., Grunze, Heinz , Frye, Mark, Grunze, Heinz , McElroy, Susan L. , Rowe, Michael J.

Mayo Clinic

Journal of Nervous & Mental Disease | May 17, 2018 | Volume: 206 | Issue: 6 | Pages: 469-472

10.1097/nmd.0000000000000819 | PMID 29781886 Get It

Abstract The relationship of personality disorder (PD) psychopathology to the course of bipolar disorder remains inadequately described. After giving informed consent, more than 782 outpatients with bipolar disorder rated themselves on the 99-item Personality Disorder Questionnaire, Version 4 (PDQ4) when depressed or euthymic. They also rated six poor prognosis factors (PPFs). The relationships of the PPFs to the total PDQ4 score were examined by a linear regression. Even after correcting for the higher PDQ4 scores observed when patients were suffering depression, the PDQ4 was significantly related to a history of child abuse, early age of onset, an anxiety disorder comorbidity, rapid cycling, and 20 or more previous episodes, but not substance abuse. The data suggest close relationships between the total burden of PD psychopathology and correlates of an adverse outcome of bipolar disorder. The nature of this of association and approaches to treatment of comorbid PD remain to be further explored.
Comparison of Fasting Human Pancreatic Polypeptide Levels Among Patients With Pancreatic Ductal Adenocarcinoma, Chronic Pancreatitis, and Type 2 Diabetes Mellitus
Kudva, Yogish C. , Chari, Suresh T. , Nagpal, Sajan Jiv Singh , Bamlet, William R. , Chari, Suresh T

Mayo Clinic

Pancreas | May 17, 2018 | Volume: 47 | Issue: 6 | Pages: 738-741

10.1097/mpa.0000000000001077 | PMID 29771765 Get It

Objectives Human pancreatic polypeptide (HPP) is a hormone secreted by the ventral pancreas. While postprandial HPP levels have been studied in chronic pancreatitis (CP) and pancreatic ductal adenocarcinoma (PDAC), there are limited data on fasting HPP in these diseases. Methods Fasting serum HPP was measured in the following groups of patients: CP with diabetes mellitus (DM) (n = 16), CP without DM (n = 34), PDAC with new-onset DM (n = 50), PDAC without DM (n = 49), new-onset type 2 DM (n = 50), and controls without DM (n = 49). Sixty-six had type 3c DM (CP with DM, n = 16; PDAC with new-onset DM, n = 50). Results Median fasting HPP levels (in picograms per milliliter) were similar among all groups. Median (interquartile range) HPP levels in new-onset type 2 DM (n = 50; 288.3 [80.1–1072.1]) were similar to those in type 3c DM (n = 66; 242.3 [64.9–890.9]) (P = 0.71). In PDAC (n = 99), HPP values were similar in pancreatic head (n = 75) versus body/tail (n = 24) tumors (245.3 [64.3–1091.3] vs 334.7 [136.1–841.5]; P = 0.95), regardless of DM. Conclusions Fasting HPP levels are similar in CP, PDAC, and controls regardless of glycemic status.
Thyrotropin Receptor Antibodies—An Overview
Kotwal, Anupam , Stan, Marius N. , Kudva, Yogish C , Stan, Marius N

Mayo Clinic

Ophthalmic Plastic & Reconstructive Surgery | May 17, 2018 | Volume: 34 | Issue: 4S | Pages: S20-S27

10.1097/iop.0000000000001052 | PMID 29771756 Get It

Purpose: Thyroid autoimmunity affects approximately 5% of the population, and its investigation relies heavily on the use of autoantibodies. Thyroid stimulating hormone receptor (TSHR) autoantibodies (TRAb) play a central role in the evaluation of Graves disease (GD), Graves ophthalmopathy (GO) and pretibial myxedema (PTM). However, there is still controversy regarding overall TRAb assay diagnostic accuracy and their prognostic utility. Methods: We reviewed and analyzed the literature reporting TRAb assays and their clinical utility. Results: Current assays measure the overall TRAb titer in a competitive manner (TSH binding inhibiting immunoglobulin assay) or biologic activity of the stimulating TSHR autoantibodies (thyroid stimulating immunoglobulin assay). Both types of assays have improved over time with advances in sensitivity and specificity. TRAb are particularly relevant in hyperthyroidism cases where use of iodinated contrast is not an option (e.g., pregnancy or recent use of iodinated contrast) or in cases of euthyroid eye disease, suspicious for GO. Third generation TRAb assays are useful for therapy selection in GD, prognostic predictions in GO and risk prediction for fetal and neonatal thyrotoxicosis. Discussion: Given the pathogenic role of TRAb, we expect that the future will bring useful evidence regarding their predictive role with respect to efficacy of therapeutic modalities for GO and PTM. We also hope to better understand the role of blocking and neutral antibodies against TSHR, and harness that ability for modulation of thyroid function or therapy of differentiated thyroid carcinoma managed with TSH suppression. Conclusions: Thyroid autoimmune diseases have seen tremendous gains in understanding their pathophysiology, largely antibody mediated. Better TRAb testing is becoming a springboard for providing individualized patient care.
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
Silberstein, Stephen D., Bigal, Marcelo E. , Yeung, Paul, Blankenbiller, Tricia , Grozinski‐Wolff, Melissa, Yang, Ronghua , Ma, Yuju, Aycardi, Ernesto, Dodick, David W. , Goadsby, Peter J.

Mayo Clinic

JAMA | May 17, 2018 | Volume: 319 | Issue: 19 | Pages: 1999

10.1001/jama.2018.4853 | PMID 29800211 Get It

Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non–Small Cell Lung Cancer
Cagney, Daniel , Catalano, Paul J. , Brown, Paul D. , Aizer, Ayal A. , Martin, Allison M. , Alexander, Brian M. , Lin, Nancy U.

Mayo Clinic

JAMA Oncology | May 17, 2018 | Volume: 4 | Issue: 7 | Pages: 1001

10.1001/jamaoncol.2018.0813 | PMID 29799956 Get It

A Cell-Based Approach to the Treatment of Inflammatory Bowel Disease—Entering an Era of Regenerative Medicine
Lightner, Amy L.

Mayo Clinic

Inflammatory Bowel Diseases | May 17, 2018 | Volume: 24 | Issue: 8 | Pages: 1689-1694

10.1093/ibd/izy084 | PMID 29788100 Get It

Pediatric Appendicitis Severity in KwaZulu‐Natal, South Africa: A Retrospective Cohort Analysis
Kong, Victor , Bruce, John , Aho, Johnathon M. , Laing, Grant , Zielinski, Martin D. , Clarke, Damian , Hernandez, Matthew C.

Mayo Clinic

World Journal of Surgery | May 17, 2018 | Volume: 42 | Issue: 11 | Pages: 3785-3791

10.1007/s00268-018-4677-8 | PMID 29777269 Get It

AbstractBackgroundAcute appendicitis is a common pediatric surgical emergency; however, there are few grading systems to assign disease severity. The American Association for the Surgery of Trauma (AAST) recently developed a grading system for a variety of emergency surgical conditions, including appendicitis. The severity of acute appendicitis in younger patients in KwaZulu‐Natal (South Africa) is unknown. We aimed to describe the disease severity in this patient population using the AAST grading system hypothesizing that the AAST grade would correlate with morbidity, management type, and duration of stay.MaterialsSingle institutional review of patients <18 years old with a final diagnosis of acute appendicitis during 2010–2016 in KwaZulu‐Natal, South Africa, was performed. Demographics, physiologic and symptom data, procedural details, postoperative complications, and Clavien–Dindo classification were abstracted. AAST grades were generated based on intraoperative findings. Summary, univariate, and nominal logistic regression analyses were performed to compare AAST grade and outcomes.ResultsA total of 401 patients were identified with median [IQR] age of 11 [5–13], 65% male. Appendectomy was performed in all patients; 2.4% laparoscopic, 37.6% limited incision, and 60% midline laparotomy. Complications occurred in 41.6%, most commonly unplanned relaparotomy (22.4%), surgical site infection (8.9%), pneumonia (7.2%), and acute renal failure (2.9%). Complication rate and median length of stay increased with greater AAST grade (all p < 0.001). AAST grade was independently associated with increased risk of complications.ConclusionPediatric appendicitis is a morbid disease in a developing middle‐income country. The AAST grading system is generalizable and accurately corresponds with management strategies as well as key clinical outcomes.Level of evidenceRetrospective study, Level IV.Study typeRetrospective single institutional study.
Systematic Review and Meta-analysis: Vedolizumab and Postoperative Complications in Inflammatory Bowel Disease
Yung, Diana E., Horesh, Nir , Ben‐Horin, Shomron , Eliakim, Rami, Koulaouzidis, Anastasios , Lightner, Amy L. , Kopylov, Uri

Mayo Clinic

Inflammatory Bowel Diseases | May 17, 2018 | Volume: 24 | Issue: 11 | Pages: 2327-2338

10.1093/ibd/izy156 | PMID 29788385 Get It

HIV-1 Activation of Innate Immunity Depends Strongly on the Intracellular Level of TREX1 and Sensing of Incomplete Reverse Transcription Products
Kumar, Swati, Morrison, James H. , Dingli, David , Poeschla, Eric M. , Dingli, David

Mayo Clinic

Journal of Virology | May 17, 2018 | Volume: 92 | Issue: 16 | Pages: No page available

10.1128/jvi.00001-18 | PMID 29769349 Get It

Much remains unknown about how TREX1 influences HIV-1 replication: whether it targets full-length viral DNA versus partial intermediates, how intracellular TREX1 protein levels correlate with ISG induction, and whether TREX1 digestion of cytoplasmic DNA and subsequent cGAS pathway activation affects both initial and subsequent cycles of infection. To answer these questions, we experimentally varied the intracellular level of TREX1 and showed that this strongly determines the innate immunogenicity of HIV-1. In addition, several lines of evidence, including time-of-addition experiments with drugs that impair reverse transcription or capsid integrity, showed that the pathogen-associated molecular patterns sensed after viral entry contain DNA, are TREX1 and cGAS substrates, and are derived from incomplete reverse transcriptase (RT) products. In contrast, the experiments demonstrate that full-length integration-competent viral DNA is immune to TREX1. Treatment approaches that reduce TREX1 levels or facilitate release of DNA intermediates may advantageously combine enhanced innate immunity with antiviral effects.